NEXT LEVEL IMMUNO-ONCOLOGY Trademark

Trademark Overview


On Friday, January 7, 2022, a trademark application was filed for NEXT LEVEL IMMUNO-ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the NEXT LEVEL IMMUNO-ONCOLOGY trademark a serial number of 97207825. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 14, 2025. This trademark is owned by Beyond Cancer, Ltd. The NEXT LEVEL IMMUNO-ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparations for treating tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparations for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium

Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases
next level immuno-oncology

General Information


Serial Number97207825
Word MarkNEXT LEVEL IMMUNO-ONCOLOGY
Filing DateFriday, January 7, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 14, 2025

Trademark Statements


Description of MarkThe mark consists of the wording "NEXT LEVEL IMMUNO-ONCOLOGY" in stylized form.
Goods and ServicesPharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparations for treating tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparations for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"IMMUNO-ONCOLOGY"
Goods and ServicesScientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBeyond Cancer, Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGarden City, NY 11530

Party NameBeyond Cancer, Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGarden City, NY 11530

Trademark Events


Event DateEvent Description
Tuesday, January 11, 2022NEW APPLICATION ENTERED
Thursday, January 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 14, 2022ASSIGNED TO EXAMINER
Monday, October 17, 2022NON-FINAL ACTION WRITTEN
Monday, October 17, 2022NON-FINAL ACTION E-MAILED
Monday, October 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023SUSPENSION LETTER WRITTEN
Wednesday, April 26, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, April 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 6, 2024FINAL REFUSAL WRITTEN
Tuesday, February 6, 2024FINAL REFUSAL E-MAILED
Tuesday, February 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 2, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, May 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 6, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, August 6, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, August 6, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, August 6, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 31, 2024ASSIGNED TO LIE
Friday, November 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 22, 2025ACTION CONTINUING FINAL - COMPLETED
Monday, September 15, 2025EXPARTE APPEAL TERMINATED
Tuesday, September 16, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 16, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, September 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 6, 2025EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Thursday, May 22, 2025NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, May 22, 2025ACTION DENYING REQ FOR RECON E-MAILED